HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity.

Abstract
Platelet aggregation and the platelet prostaglandin pathway have been investigated in two patients with preleukaemic states who had a haemorrhagic tendency but a normal platelet count. In both patients platelet aggregation induced by collagen adenosine diphosphate (ADP) and arachidonic acid (AA) were abnormal. Malonyldiadehyde (MDA) production from exogenous AA was normal in both patients thus excluding cyclo-oxygenase deficiency. The platelet aggregating and rabbit aorta contracting activities of thromboxane A2 (TxA2) were very low in both patients. Production of thromboxane B2 (TxB2) assessed by thin layer chromatographic separation of the metabolites of [1(-14)C]AA and by radioimmunoassay, was normal. These abnormalities of platelet function appear to be due to the production of TxA2 with a low biological activity.
AuthorsN H Russell, J P Keenan, A J Bellingham
JournalBritish journal of haematology (Br J Haematol) Vol. 41 Issue 3 Pg. 417-25 (Mar 1979) ISSN: 0007-1048 [Print] England
PMID570847 (Publication Type: Journal Article)
Chemical References
  • Adenine Nucleotides
  • Thromboxanes
  • Thromboxane B2
  • Thromboxane A2
Topics
  • Adenine Nucleotides (blood)
  • Blood Platelet Disorders (etiology)
  • Blood Platelets (analysis)
  • Female
  • Humans
  • Male
  • Platelet Aggregation
  • Preleukemia (complications)
  • Thromboxane A2 (physiology)
  • Thromboxane B2 (blood)
  • Thromboxanes (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: